Greenwell Scott A. 4

What Happened

• Scott A. Greenwell, President of PharMerica (a BrightSpring business), received equity awards on March 5, 2026. The filing shows two grant entries: 20,020 shares (award) and 49,073 derivative shares (RSUs), for a total of 69,093 restricted stock units. Each award was recorded at $0.00 acquisition price (typical for RSU compensation).

Key Details

• Transaction date: 2026-03-05; Form 4 filed: 2026-03-06.
• Grants recorded: 20,020 shares (A) and 49,073 derivative RSUs (A) — total 69,093 RSUs.
• Reported acquisition price: $0.00 per unit (no cash paid at grant).
• Vesting (Footnote F1): RSUs vest in three equal annual installments beginning January 25, 2027; each RSU represents a contingent right to one share upon settlement.
• Additional footnote (F2): notes a three-year annual vesting pattern for options (the current filing reports RSU grants, not option exercises).
• Shares owned after the transaction: not specified in the provided filing.
• Timeliness: Filing was submitted the day after the grants—no late filing flag indicated.

Context

• These awards are compensation grants (RSUs), not open-market purchases or sales. RSUs do not deliver shares immediately; they convert to shares only as they vest per the schedule above.
• Such grants are common for executive pay and are not direct evidence of buying or selling sentiment.